Investments
31Portfolio Exits
2Funds
1Partners & Customers
2About Lingotto
Lingotto through its subsidiaries, engages in the reinsurance, automotive, agricultural equipment, construction equipment and commercial vehicles, and football businesses. The company reinsures agriculture, aviation/space, casualty, catastrophe, energy, engineering, financial, marine, motor, multiline, and property risks, as well as offers mortality, longevity, accident and health, and alternative risk products. It was formerly known as EXOR. The company is based in Amsterdam, Netherlands.
Want to inform investors similar to Lingotto about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Lingotto News
May 22, 2023
May 22, 2023 02:10 ET Amsterdam, NETHERLANDS EXOR N.V. (AMS: EXO) (“Exor” or the “Company”) announces that, under the third tranche of the share buyback program of up to €150 million announced on 17 April 2023 (the “third tranche”), the Company has completed the following transactions on Euronext Amsterdam and CBOE DXE: EURONEXT AMSTERDAM Average price per share excluding fees (€) Total consideration excluding fees (€) Average price per share excluding fees (€) Total consideration excluding fees (€) 8,599,081.56 After these purchases, the total invested amount under the third tranche is approximately €66.8 million for a total amount of 872,429 ordinary shares purchased. As of 19 May 2023, the Company held in total 8,248,643 ordinary shares in treasury (3.53% of total ordinary issued share capital)1. 1 This corresponds to 1.13% of the total issued share capital including both ordinary shares and special voting shares. A comprehensive overview of the transactions carried out under the share buyback program, as well as the details of the above transactions, are available on Exor’s corporate website under the Share Buyback section . Attachment
Lingotto Investments
31 Investments
Lingotto has made 31 investments. Their latest investment was in Orbital Therapeutics as part of their Series A on April 4, 2023.
Lingotto Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
4/26/2023 | Series A | Orbital Therapeutics | $270M | Yes | Abu Dhabi Growth Fund, Agent Capital, Alexandria Venture Investments, Andreessen Horowitz, ARCH Venture Partners, Casdin Capital, Heritage Medical Systems, iGlobe Partners, Invus Group, Lingotto, Moore Strategic Ventures, Newpath Partners, Redmile Group, Rellim Capital Management, and Undisclosed Investors | 11 |
3/14/2023 | Series B | Verity | $32M | Yes | AP Moller Holding, EXOR Seeds, Lingotto, and Undisclosed Investors | 6 |
2/13/2023 | Series H | Via | $110M | No | 3 | |
12/15/2022 | Series C - II | |||||
11/22/2022 | Series D - II |
Date | 4/26/2023 | 3/14/2023 | 2/13/2023 | 12/15/2022 | 11/22/2022 |
|---|---|---|---|---|---|
Round | Series A | Series B | Series H | Series C - II | Series D - II |
Company | Orbital Therapeutics | Verity | Via | ||
Amount | $270M | $32M | $110M | ||
New? | Yes | Yes | No | ||
Co-Investors | Abu Dhabi Growth Fund, Agent Capital, Alexandria Venture Investments, Andreessen Horowitz, ARCH Venture Partners, Casdin Capital, Heritage Medical Systems, iGlobe Partners, Invus Group, Lingotto, Moore Strategic Ventures, Newpath Partners, Redmile Group, Rellim Capital Management, and Undisclosed Investors | AP Moller Holding, EXOR Seeds, Lingotto, and Undisclosed Investors | |||
Sources | 11 | 6 | 3 |
Lingotto Portfolio Exits
2 Portfolio Exits
Lingotto has 2 portfolio exits. Their latest portfolio exit was PartnerRe on July 12, 2022.
Lingotto Acquisitions
5 Acquisitions
Lingotto acquired 5 companies. Their latest acquisition was Welltec on June 08, 2021.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
6/8/2021 | Other | Corporate Majority | 2 | |||
12/10/2020 | ||||||
3/18/2016 | ||||||
8/12/2015 | ||||||
3/1/1992 | Growth Equity |
Date | 6/8/2021 | 12/10/2020 | 3/18/2016 | 8/12/2015 | 3/1/1992 |
|---|---|---|---|---|---|
Investment Stage | Other | Growth Equity | |||
Companies | |||||
Valuation | |||||
Total Funding | |||||
Note | Corporate Majority | ||||
Sources | 2 |
Lingotto Fund History
1 Fund History
Lingotto has 1 fund, including Cars24 SPV.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
Cars24 SPV | 1 |
Closing Date | |
|---|---|
Fund | Cars24 SPV |
Fund Type | |
Status | |
Amount | |
Sources | 1 |
Lingotto Partners & Customers
2 Partners and customers
Lingotto has 2 strategic partners and customers. Lingotto recently partnered with Institut Merieux on July 7, 2022.
Date | Type | Business Partner | Country | News Snippet | Sources |
|---|---|---|---|---|---|
7/1/2022 | Partner | France | NET ASSET VALUE (NAV). Exor’s Board of Directors approves Half-Year 2022 Results. Creation of the new long-term partnership between Exor Seeds and Institut Mérieux in global healthcare . | 2 | |
4/7/2013 | Partner |
Date | 7/1/2022 | 4/7/2013 |
|---|---|---|
Type | Partner | Partner |
Business Partner | ||
Country | France | |
News Snippet | NET ASSET VALUE (NAV). Exor’s Board of Directors approves Half-Year 2022 Results. Creation of the new long-term partnership between Exor Seeds and Institut Mérieux in global healthcare . | |
Sources | 2 |
Lingotto Team
2 Team Members
Lingotto has 2 team members, including current Managing Director, Noam Ohana.
Name | Work History | Title | Status |
|---|---|---|---|
Noam Ohana | Atticus Capital | Managing Director | Current |
Name | Noam Ohana | |
|---|---|---|
Work History | Atticus Capital | |
Title | Managing Director | |
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.